Fatal intra-alveolar hemorrhage after rituximab in a patient with non-Hodgkin lymphoma

Leukemia and Lymphoma

Volumn 45, Issue 11, 2004, Pages 2321-2325

  Alexandrescu, Doru T ^a   Dutcher, Janice P ^a   O'Boyle, Kevin ^a   Albulak, Mehmet ^a   Oiseth, Stanley ^a   Wiernik, Peter H ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Alveolar hemorrhage; Hypersensitivity pneumonitis; Interstitial lung reaction; Rituximab

Indexed keywords

ALEMTUZUMAB; ANTIBIOTIC AGENT; CD20 ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOKINE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; METHOTREXATE; MITOXANTRONE; OKT 3; PREDNISONE; RITUXIMAB; VINCRISTINE;

AGED; AUTOIMMUNE HEMOLYTIC ANEMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CASE REPORT; COUGHING; CYTOTOXIC T LYMPHOCYTE; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; EOSINOPHIL; FARMER LUNG; HELPER CELL; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOLOGY; LEUKOCYTE COUNT; LUNG BIOPSY; LUNG DISEASE; LUNG HEMORRHAGE; MALE; NEUTROPENIA; NONHODGKIN LYMPHOMA; ORGANIZING PNEUMONIA; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; PROGRESSIVE PIGMENTED PURPURA; RASH; REVIEW; SEROLOGY; STEVENS JOHNSON SYNDROME; SUPPRESSOR CELL; SYMPTOMATOLOGY; VASCULITIS;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CYCLOPHOSPHAMIDE; DOXORUBICIN; EOSINOPHILS; FATAL OUTCOME; GRANULOMA; HEMORRHAGE; HUMANS; IMMUNOGLOBULIN E; INFLAMMATION; LYMPHOMA, NON-HODGKIN; MALE; PIGMENTATION DISORDERS; PREDNISOLONE; PULMONARY ALVEOLI; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VINCRISTINE;

EID: 8644274721     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190410001697359     Document Type: Review

References (28)

1. Winkler, U., Jensen, M., Manzke, O., et al. (1999) "Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody(rituximab, IDEC-C2B8)", Blood, 94, 2217-2224.
2. Shimoni, A., et al. (2003) "Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma", Br. J. Haematol., 122, 457-464.
3. Maloney, D.G., Smith, B. and Rose, A. (2002) "Rituximab: mechanism of action and resistance", Semin. Oncol., 29, 2-9.
4. Lowndes, S., Darby, A., Mead, G. and Lister, A. (2002) "Stevens-Johnson syndrome after treatment with rituximab", Ann. Oncol., 13, 1948-1950.
5. Jourdan, E., Topart, D., Richard, B., et al. (2003) "Severe autoimmune hemolytic anemia following rituximab therapy in a patient with a lymphoproliferative disorder", Leuk. Lymphoma, 44, 889-890.
6. Voog, E,, Morschhauser, F. and Solal-Celigny, P. (2003) "Neutropenia in patients treated with rituximab", N. Engl. J. Med. 348, 2691-2694.
7. Dereure, O., Navarro, R., Rossi, J.F. and Guilhou, J.J. (2001) "Rituximab-induced vasculitis", Dermatology, 203, 83-84.
8. Kanelli, S., Ansell, S.M., Habermann, T.M., et al. (2001) "Rituximab toxicity in patients with peripheral blood malignant B-cell lymphocytosis", Leuk. Lymphoma, 42, 1329-1337.
9. Burton, C., Kaczmarski, R. and Jan-Mohamed, R. (2003) "Interstitial pneumonitis related to rituximab therapy", N. Engl. J. Med., 348, 2690-2691.
10. Byrd, J.C., Peterson, B.L., Morrison, V.A., et al. (2002) "Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)", Blood, 101, 6-14.
11. Hainsworth, J.D., Litchy, S., Lamb, M.R., et al. (2003) "First-line treatment with brief-duration chemotherapy plus rituximab in elderly patients with intermediate-grade non-Hodgkin's lymphoma: phase II trial", Clin. Lymphoma, 4, 36-42.
12. Genetech Report, Rituxan and Pulmonary Events, 2003.
13. van der Kolk, L.E., Grillo-Lopez, A.J., Baars, J.W., et al. (2001) "Complement activation plays a key role in the side-effects of rituximab treatment", Br. J. Haematol., 115, 807-811.
14. Wing, M.G., Moreau, T., Greenwood, J., et al. (1996) "Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FegammaRIII) and CD11a/CD18 (LFA-1) on NK cells", J. Clin. Invest., 98, 2819-2826.
15. Moreau, T., Coles, A., Wing, M., et al. (1996) "CAMPATH-IH in multiple sclerosis", Mult. Scler., 1, 357-365.
16. Gaston, R.S., Deierhoi, M.H., Patterson, T., et al. (1991) "OKT3 first-dose reaction: association with T cell subsets and cytokine release", Kidney Int., 39, 141-148.
17. Headley, A.S., Tolley, E. and Meduri, G.U. (1997) "Infections and the inflammatory response in acute respiratory distress syndrome", Chest, 111, 1306-1321.
18. Griffin, G.E. (1998) "Cytokines involved in human septic shock-the model of the Jarisch-Herxheimer reaction", J. Antimicrob. Chemother., 41, 25-29.
19. Selenko, N., Maidic, O., Draxier, S., et al. (2001) "CD20 antibody (C2B8)-induced apoptosis of lymphoma cells promotes phagocytosis by dendritic cells and cross-priming of CD8 + cytotoxic T cells", Leukemia, 15, 1619-1626.
20. Hultin, L.E., Hausner, M.A., Hultin, P.M. and Giorgi, J.V. (1993) "CD20 (pan-B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes", Cytometry, 14, 196-204.
21. Algino, K.M., Thomason, R.W., King, D.E., et al. (1996) "CD20 (pan-B cell antigen) expression on bone marrow-derived T cells", Am. J. Clin. Pathol., 106, 78-81.
22. Warzynski, M.J., Graham, D.M., Axtell, R.A., et al. (1994) "Low level CD20 expression on T cell malignancies", Cytometry 15, 88-92.
23. Murayama, J., Yoshizawa, Y., Ohtsuka, M. and Hasegawa S. (1993) "Lung fibrosis in hypersensitivity pneumonitis. Association with CD4 + but not CD8 + cell dominant alveolitis and insidious onset", Chest, 104, 38-43.
24. Tada, S., Namba, J., Sugimoto, K., et al. (1992) "Studies on the T-cell subset in lung tissue and BALF from patients with interstitial pneumonia", Arerugi, 41, 577-583.
25. Salaffi, F., Manganelli, P., Carotti, M., et al. (1997) "Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature", Clin. Rheumatol., 16, 296-304.
26. Tomichi, N., Yagawa, K., Takayama, K., et al. (1989) "Immunohistochemical study of T cell subsets in lung tissue and in BALF of patients with farmer's lung disease", Arerugi, 38, 508-512.
27. Shimizu, S., Yoshinouchi, T., Ohtsuki, Y., et al. (2002) "The appearance of S-100 protein-positive dendritic cells and the distribution of lymphocyte subsets in idiopathic nonspecific interstitial pneumonia", Respir. Med., 96, 770-776.
28. Yoshioka, Y., Ohwada, A., Dambara, T. and Fukuchi, Y. (2002) "CD4 + T cells in lung tissue predict responsiveness to cyclosporin A in interstitial pneumonia", Respirology, 7, 299-304.